DBV Technologies S.A. (DBVT) stock

DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 6/30

$11.43−0.45 (-3.79%)

Close on Nov 12, 2026Market cap $718.69MP/E –Yield –

DBV Technologies price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

DBV Technologies's price to book ratio was 4.2× on Nov 10, 2026, against 6.8× a year earlier. Over the last 5 years it ranged from 0.1× to 65.0×, with a median of 0.4×.

Price to Book Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 10, 2026	4.2×	−5.7
2025	Dec 31, 2025	9.9×	+8.8
2024	Dec 31, 2024	1.1×	+0.8
2023	Dec 29, 2023	0.3×	+0.1
2022	Dec 30, 2022	0.2×	−0.1
2021	Dec 31, 2021	0.3×	+0.0
2020	Dec 31, 2020	0.3×	−0.7
2019	Dec 31, 2019	0.9×	–

Where these numbers come from

Parsed from the XBRL in DBV Technologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2 reverse split on Jun 7, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing